These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32884613)

  • 41. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
    Swallow MA; Fan R; Cohen JM; Bunick CG
    Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Systemic antibiotic therapy of acne vulgaris].
    Ochsendorf F
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S31-46. PubMed ID: 20482690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
    Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives.
    Castillo DE; Nanda S; Keri JE
    Dermatol Ther (Heidelb); 2019 Mar; 9(1):19-31. PubMed ID: 30539425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Proteomic Analysis of Membrane Vesicles from Clinical
    Jiang M; Fan X; Jiang Z; Chen H; Liu Y; Yu T; Huang Q; Ma Y
    Clin Cosmet Investig Dermatol; 2022; 15():703-712. PubMed ID: 35463830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial Susceptibility of
    Solís MB; Zurita J; Velasco N; Dressendorfer LM
    Skinmed; 2018; 16(3):159-165. PubMed ID: 29989535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics.
    Park SY; Kim HS; Lee SH; Kim S
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections.
    Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H
    J Glob Antimicrob Resist; 2022 Mar; 28():151-157. PubMed ID: 35017069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-antibiotic Isotretinoin Treatment Differentially Controls
    Ryan-Kewley AE; Williams DR; Hepburn N; Dixon RA
    Front Microbiol; 2017; 8():1381. PubMed ID: 28790988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.